Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Biochemical Reagents >  Agonist Inhibitors >  PLpro inhibitor

PLpro inhibitor

Basic information Safety Supplier Related

PLpro inhibitor Basic information

Product Name:
PLpro inhibitor
Synonyms:
  • PLpro inhibitor
  • 5-(Acetylamino)-2-methyl-N-[(1R)-1-(1-naphthalenyl)ethyl]benzamide
  • 5-Acetylamino-2-methyl-N-(1R-naphthalen-1-yl-ethyl)benzamide
  • 5-(acetylamino)-2-methyl-N-[(1R)-1-(1-naphthalenyl)ethyl]-
  • BENZAMIDE; 5-(ACETYLAMINO)-2-METHYL-N-[(1R)-1-(1-NAPHTHALENYL)ETHYL]-
  • 5-acetamido-2-methyl-N-[2-(1-naphthalenyl)ethyl]benzamide
  • 5-acetylamino-2-methyl-N-[(R)-1-(1-naphthyl)ethyl]benzamide
  • 5-acetamido-2-methyl-n-(2-naphthalen-1-ylethyl)benzamide
CAS:
1093070-14-4
MF:
C22H22N2O2
MW:
346.42
Mol File:
1093070-14-4.mol
More
Less

PLpro inhibitor Chemical Properties

Boiling point:
584.7±50.0 °C(Predicted)
Density 
1.189±0.06 g/cm3(Predicted)
storage temp. 
Sealed in dry,Room Temperature
solubility 
DMF: 30 mg/ml; DMSO: 30 mg/ml
form 
Powder
pka
14.13±0.46(Predicted)
color 
White to off-white
More
Less

PLpro inhibitor Usage And Synthesis

Uses

PLpro inhibitor is a potent inhibitor of papain-like protease (PLpro) with an IC50 of 2.6 μM[1]. PLpro inhibitor inhibits SARS-CoV-2 PLpro with an IC50 of 5.0 μM and an EC50 of 21.0 μM[2].

Definition

ChEBI: KOM70144 is a benzamide that is GRL-0617 in which one of the hydrogen's of the primary amino group is replaced by an acetyl group. It an inhibitor of SARS-CoV and SARS-CoV-2 papain-like protease (PLpro) with an IC50 of 2.6 muM and 5.0 muM, respectively. It also inhibits SARS-CoV and SARS-CoV-2 infection of Vero E6 cells in vitro (EC50 values are 13.1 and 21 muM, respectively). It has a role as a protease inhibitor and an anticoronaviral agent. It is a member of naphthalenes, a member of benzamides, a secondary carboxamide and a member of acetamides. It is functionally related to a GRL-0617.

storage

Store at -20°C

References

[1] Ratia, K., et al., A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication. Proc Natl Acad Sci U S A, 2008. 105(42): p. 16119-24. DOI:10.1073/pnas.0805240105
[2] http://www.google.com/patents/WO2010022355A1cl=en
[3] Brendan T Freitas, et al. Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease. ACS Infect Dis. 2020 May 19. DOI:10.1021/acsinfecdis.0c00168

PLpro inhibitorSupplier

Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Email
info@chemexpress.com
MedChemexpress LLC
Tel
021-58955995
Email
sales@medchemexpress.cn
LETOPHARM LIMITED
Tel
+86-21-5821 5861
Email
sales@letopharm.com
SPIRO PHARMA
Tel
Email
eric_feng1954@126.com
BOC Sciences
Tel
16314854226
Email
info@bocsci.com